Poids de l’Open access dans la production CNRS
Home
Resources
Graphs
Search
Export
Sign in
Titre
PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer
XX
BSO - Titre
PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer
XX
DOI
DOI
10.1016/j.ejca.2017.08.025
XX
DOAI
DOAI
10.1016/j.ejca.2017.08.025
XX
Identifiant WoS
WOS:000414850400004
XX
Accès ouvert
OA - Non
XX
Source - Accès ouvert
OA - Non
XX
Type d'accès
Non OA
XX
Editeur
Elsevier
XX
Source
EUROPEAN JOURNAL OF CANCER
XX
ISSN
0959-8049
XX
Type de document
Article
XX
Notoriété
4 - Excellente
XX
CNRS
Oui
XX
CNRS - Institut
INSB - Institut des sciences biologiques
XX
uid:/JQH13Q5T
12/10/2021 14:52:56 (latest)
Add field
Share/Export
Powered by
Lodex
9.6.0
